Parabens inhibit the endocannabinoid enzyme fatty acid amide hydrolase (FAAH).
Paraben inhibition has time-independent, mixed-type kinetics.
Benzylparaben, the most potent paraben, inhibits FAAH with sub-micromolar potency.
Endocannabinoids may mediate paraben-enhanced adipogenesis but not through CB1 activation.